These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6460502

  • 1. DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin.
    Yamamoto H, Uchigata Y, Okamoto H.
    Biochem Biophys Res Commun; 1981 Dec 15; 103(3):1014-20. PubMed ID: 6460502
    [No Abstract] [Full Text] [Related]

  • 2. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H, Yamamoto H.
    Princess Takamatsu Symp; 1983 Dec 15; 13():297-308. PubMed ID: 6317640
    [Abstract] [Full Text] [Related]

  • 3. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets.
    Yamamoto H, Uchigata Y, Okamoto H.
    Nature; 1981 Nov 19; 294(5838):284-6. PubMed ID: 6272129
    [No Abstract] [Full Text] [Related]

  • 4. [Structural and enzymatic changes in the islets of the rat pancreas following alloxan and streptozotocin administration].
    Hettwer H, Dahlmann B, Marjanovic SD.
    Cell Mol Biol Incl Cyto Enzymol; 1978 Nov 19; 23(4):355-67. PubMed ID: 162617
    [No Abstract] [Full Text] [Related]

  • 5. Chemiluminescence as an index of drug-induced free radical production in pancreatic islets.
    Asayama K, English D, Slonim AE, Burr IM.
    Diabetes; 1984 Feb 19; 33(2):160-3. PubMed ID: 6229439
    [Abstract] [Full Text] [Related]

  • 6. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis.
    Uchigata Y, Yamamoto H, Kawamura A, Okamoto H.
    J Biol Chem; 1982 Jun 10; 257(11):6084-8. PubMed ID: 6281256
    [Abstract] [Full Text] [Related]

  • 7. Streptozocin- and alloxan-induced H2O2 generation and DNA fragmentation in pancreatic islets. H2O2 as mediator for DNA fragmentation.
    Takasu N, Komiya I, Asawa T, Nagasawa Y, Yamada T.
    Diabetes; 1991 Sep 10; 40(9):1141-5. PubMed ID: 1834504
    [Abstract] [Full Text] [Related]

  • 8. Alloxan-induced DNA strand breaks in pancreatic islets. Evidence for H2O2 as an intermediate.
    Takasu N, Asawa T, Komiya I, Nagasawa Y, Yamada T.
    J Biol Chem; 1991 Feb 05; 266(4):2112-4. PubMed ID: 1989973
    [Abstract] [Full Text] [Related]

  • 9. Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro.
    Sandler S, Swenne I.
    Diabetologia; 1983 Nov 05; 25(5):444-7. PubMed ID: 6228481
    [Abstract] [Full Text] [Related]

  • 10. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.
    Szkudelski T.
    Physiol Res; 2001 Nov 05; 50(6):537-46. PubMed ID: 11829314
    [Abstract] [Full Text] [Related]

  • 11. Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice.
    Gaulton GN, Schwartz JL, Eardley DD.
    Diabetologia; 1985 Oct 05; 28(10):769-75. PubMed ID: 2933286
    [Abstract] [Full Text] [Related]

  • 12. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W, Schott-Ohly P, Schulte im Walde S, Gleichmann H.
    Exp Clin Endocrinol Diabetes; 2004 Jan 05; 112(1):29-37. PubMed ID: 14758569
    [Abstract] [Full Text] [Related]

  • 13. DNA repair synthesis in the pancreatic islets of streptozotocin-treated mice.
    Sandler S, Swenne I.
    Diabetes Res; 1985 Sep 05; 2(5):255-8. PubMed ID: 2933209
    [Abstract] [Full Text] [Related]

  • 14. Intermediate cells of the pancreas. 3. Selective autophagy and destruction of beta-granules in intermediate cells of the rat pancreas induced by alloxan and streptozotocin.
    Melmed RN, Benitez CJ, Holt SJ.
    J Cell Sci; 1973 Jul 05; 13(1):297-315. PubMed ID: 4269735
    [No Abstract] [Full Text] [Related]

  • 15. Islet cell membrane alteration by diabetogenic drugs.
    Orci L, Amherdt M, Malaisse-Lagae F, Ravazzola M, Malaisse WJ, Perrelet A, Renold AE.
    Lab Invest; 1976 May 05; 34(5):451-4. PubMed ID: 131879
    [Abstract] [Full Text] [Related]

  • 16. Streptozotocin diabetes--further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver.
    Schein PS, Cooney DA, McMenamin MG, Anderson T.
    Biochem Pharmacol; 1973 Oct 15; 22(20):2625-31. PubMed ID: 4357891
    [No Abstract] [Full Text] [Related]

  • 17. Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B cell cytotoxicity.
    Lazarus SS, Shapiro SH.
    Diabetes; 1973 Jul 15; 22(7):499-506. PubMed ID: 4146293
    [No Abstract] [Full Text] [Related]

  • 18. [Vasoactive intestinal polypeptide(VIP)- and insulin-producing cells--molecular biology, physiology and pathology].
    Okamoto H.
    Nihon Naibunpi Gakkai Zasshi; 1984 Dec 20; 60(12):1449-63. PubMed ID: 6099284
    [No Abstract] [Full Text] [Related]

  • 19. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis.
    Uchigata Y, Yamamoto H, Nagai H, Okamoto H.
    Diabetes; 1983 Apr 20; 32(4):316-8. PubMed ID: 6299867
    [Abstract] [Full Text] [Related]

  • 20. A comparison of the effects of streptozotocin, N-methylnitrosourea and alloxan on isolated islets of Langerhans.
    Akpan JO, Wright PH, Dulin WE.
    Diabete Metab; 1987 Apr 20; 13(2):122-8. PubMed ID: 2954869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.